ClinicalTrials.Veeva

Menu

Cardiovascular Risk Factors in an Ambulatory Urban Patient Population (AsuRiesgo)

H

Heidelberg University

Status

Completed

Conditions

Coronary Artery Disease
Lifestyle Modification
Stroke
Cardiovascular Risk Factors
Metabolic Syndrome

Treatments

Behavioral: Dietary and nutritional modification
Behavioral: Regular intake of polyphenols, esp. from Ilex paraguayensis
Behavioral: Regular physical activities
Behavioral: Weight reduction to normal ranges
Behavioral: Stop smoking

Study type

Observational

Funder types

Other

Identifiers

NCT00486993
AsuRiesgo

Details and patient eligibility

About

According to WHO estimations, cardiovascular diseases (CVDs) are the number one cause of death globally. More people die annually from CVDs than from any other cause. An estimated 17.5 million people died from CVDs in 2005, representing 30% of all global deaths. Of these deaths, an estimated 7.6 million were due to coronary heart disease and 5.7 million were due to stroke.

Over 80% of CVD deaths take place in low- and middle-income countries and occur almost equally in men and women. In Paraguay, prevalence of classic risk factors, as well as new ones, like the metabolic syndrome are not completely known.

Government health policies in industrialized countries are focusing on programs to modify cardiovascular risk factors. In developing countries, prevention of coronary heart disease and stroke through modification of cardiovascular risk factors are not playing a large role at the moment.

The aim of this study is to define the effects of changes in lifestyle on cardiovascular risk factors, when added to optimized standard pharmacological therapy for arterial hypertension, diabetes mellitus and hyperlipidemia, in an ambulatory urban patient population.

Enrollment

18,287 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • all ambulatory patients, with age 18 years or older

Exclusion criteria

  • no exclusion criteria provided, particularly for the first, epidemiological part of the study

Trial design

18,287 participants in 1 patient group

asuriesgo
Description:
unselected outpatient population
Treatment:
Behavioral: Stop smoking
Behavioral: Regular intake of polyphenols, esp. from Ilex paraguayensis
Behavioral: Dietary and nutritional modification
Behavioral: Weight reduction to normal ranges
Behavioral: Regular physical activities

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems